A new research complex, the Centres for Health Research, was officially opened on Monday at the Princess Alexandra Hospital to house 140 scientists from the University of Queensland and the Princess Alexandra Hospital. [ + ]

A post-Bio 2002 debriefing session organised by AusBiotech and the BioMelbourne Network this week had one big message for future delegations - planning, planning, planning. [ + ]

Brisbane biotech CBio is set to conclude an 11-month, $5 million capital raising that coincided with the worst investor environment in a decade. [ + ]

A New Zealand company working on a pig-derived cure for type 1 diabetes has denied reports of a planned move to Australia. [ + ]

A consortium of Australia's top kidney scientists has come together with the ambitious goal of using stem cells to engineer a bioartificial organ. [ + ]

Artificial heart device developer Ventracor has appointed a new director to its ranks. [ + ]

The US is embracing Sirtex Medical's novel anti-cancer technology more quickly than Australia where government evaluation of the technology appears to have stalled. [ + ]

Along with space suits, freeze-dried food and barf bags, tomorrow's astronauts may travel with nanomolecular devices inside their white blood cells to detect early signs of damage from dangerous radiation or infection.

Australian biomedical research developer Circadian Technologies has appointed an accountant with a diverse business background to its board. [ + ]

Sydney company Peptech is hinging its hopes for a positive second half result on the issuing of US patents for its anti tumour nectrotising factor. [ + ]

A board reshuffle aimed at sharpening the focus of Adelaide biotherapy company BresaGen is underway. The company has announced the resignations of three board members and the appointment of an existing director to the chairman's position. [ + ]

Polls claiming to illustrate community views on genetic modification should be interpreted with caution because they did not always take into account a person's knowledge of the topic, a New Zealand academic has warned. [ + ]

New Zealand based Genesis Research and Development Corporation will get $NZ6 million from the Foundation for Research Science and Technology to discover and investigate new plant hormones and signalling processes. [ + ]

Collaborative agreements between researchers at the Queensland Department of Primary Industries and three major US universities - Texas A&M University, Texas Tech and the University of Missouri - could lead to development of drought resistant crops. [ + ]

Potential users of Australia's national synchrotron need to start planning now, according to Sir Peter Williams, president of the UK Institute of Physics and proponent of the synchrotron project. [ + ]